Bioorganic & Medicinal Chemistry Letters 1999-03-08

Solid-phase synthesis of benzisothiazolones as serine protease inhibitors.

K L Yu, R Civiello, D G Roberts, S M Seiler, N A Meanwell

Index: Bioorg. Med. Chem. Lett. 9(5) , 663-6, (1999)

Full Text: HTML

Abstract

An efficient solid-phase synthesis of benzisothiazolone-1,1-dioxide-based serine protease inhibitors involving alkylation of carboxylic acids with N-(bromomethyl)benzisothiazolone-1,1-dioxide has been developed. An example using this procedure for preparation of a library of human mast cell tryptase inhibitors is described.


Related Compounds

Related Articles:

Benzisothiazolinone as a useful template for the design of new monoacylglycerol lipase inhibitors: investigation of the target residues and comparison with octhilinone.

2011-12-15

[Bioorg. Med. Chem. Lett. 21(24) , 7321-4, (2011)]

A colorimetric assay for high-throughput screening of inhibitors of herpes simplex virus type 1 alkaline nuclease.

2001-06-15

[Anal. Biochem. 293(2) , 239-45, (2001)]

ppGpp accumulation in Pseudomonas aeruginosa and Pseudomonas fluorescens subjected to nutrient limitation and biocide exposure.

1999-11-01

[Lett. Appl. Microbiol. 29(5) , 298-302, (1999)]

Comparison of in vitro and ex vivo antiplatelet effects of 1,2-benzisothiazolin-3-one and its 2-amino derivative.

1999-11-01

[Arzneimittelforschung 49(11) , 896-9, (1999)]

Systemic allergic dermatitis following airborne exposure to 1,2-benzisothiazolin-3-one.

2012-11-01

[Contact Dermatitis 67(5) , 310-2, (2012)]

More Articles...